139 related articles for article (PubMed ID: 7998125)
1. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
Räisänen-Sokolowski A; Myllärniemi M; Häyry P
Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
[No Abstract] [Full Text] [Related]
2. Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443).
Räisänen-Sokolowski A; Aho P; Myllärniemi M; Kallio E; Häyry P
Transplant Proc; 1995 Feb; 27(1):435. PubMed ID: 7879051
[No Abstract] [Full Text] [Related]
3. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants.
Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124
[No Abstract] [Full Text] [Related]
4. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
[TBL] [Abstract][Full Text] [Related]
5. Clinical and experimental chronic allograft rejection.
Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen A; Koskinen P; Ustinov J; Lautenschalger I; Taskinen E
Transplant Proc; 1994 Jun; 26(3):1702-3. PubMed ID: 8030092
[No Abstract] [Full Text] [Related]
6. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
[No Abstract] [Full Text] [Related]
7. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
[No Abstract] [Full Text] [Related]
8. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
MacDonald AS; Sabr K; MacAuley MA; McAlister VC; Bitter-Suermann H; Lee T
Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
[No Abstract] [Full Text] [Related]
9. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.
Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST
Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343
[TBL] [Abstract][Full Text] [Related]
10. Effects of immunosuppressive therapy on the rat aortic allograft model.
Steele DM; Hullett DA; Bechstein WO; Kowalski J; Smith LS; Kennedy E; Allison AC; Sollinger HW
Transplant Proc; 1993 Feb; 25(1 Pt 1):754-5. PubMed ID: 8438469
[No Abstract] [Full Text] [Related]
11. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
Lácha J; Lehmann M; Chadimová M; Brock J; Havlícková J
Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129
[No Abstract] [Full Text] [Related]
12. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
[TBL] [Abstract][Full Text] [Related]
13. Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy.
Cottrell BL; Perez-Abadia G; Onifer SM; Magnuson DS; Burke DA; Grossi FV; Francois CG; Barker JH; Maldonado C
Plast Reconstr Surg; 2006 Sep; 118(3):615-23; discussion 624-5. PubMed ID: 16932168
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
[TBL] [Abstract][Full Text] [Related]
15. Reduction of transplant arteriosclerosis after treatment with mycophenolate mofetil and ganciclovir in a mouse aortic allograft model.
Hoffmann J; Böhm M; Abele-Ohl S; Ramsperger-Gleixner M; Spriewald BM; Zinser E; Steinkasserer A; Weyand M; Ensminger SM
Exp Clin Transplant; 2012 Dec; 10(6):592-600. PubMed ID: 23110396
[TBL] [Abstract][Full Text] [Related]
16. The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model.
Cole O; Rigg K; Shehata M
Ann R Coll Surg Engl; 2001 Jul; 83(4):235-43. PubMed ID: 11518369
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts.
Räisänen-Sokolowski A; Vuoristo P; Myllärniemi M; Yilmaz S; Kallio E; Häyry P
Transpl Immunol; 1995 Dec; 3(4):342-51. PubMed ID: 8665154
[TBL] [Abstract][Full Text] [Related]
18. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection.
Mennander A; Paavonen T; Häyry P
Transplant Proc; 1992 Feb; 24(1):341. PubMed ID: 1539306
[No Abstract] [Full Text] [Related]
20. Effect of cyclosporine and some derivatives on chronic rejection.
Lu X; Dawson J; Borel JF
Transplant Proc; 1996 Dec; 28(6):3152-3. PubMed ID: 8962221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
